A major infusion-care shakeup is underway. Shore Capital Partners has merged Reliant Healthcare and Care Fusion Rx to create a nationwide infusion therapy platform spanning home and ambulatory centers — with meaningful implications for GI patients on biologics, IVIG, and chronic infusion regimens.
The new entity blends Reliant’s Southern U.S. footprint with Care Fusion’s West Coast strength in complex therapies, aiming to expand access, streamline coordination with physicians, and accelerate growth through new centers and acquisitions. With leadership from industry veterans and backing from a $14B private equity firm, the platform signals a push toward more scalable, patient-centric infusion delivery.